ArticleMicrobial cell factories2025
Exploring black soil microbiota for industrial enzymes: cellulase and xylanase characterization from Bacillus subtilis SSMK413.
Article in Microbial cell factories, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Whole-genome analysis and enzymatic profiling of Bacillus spizizenii as a xylanase-producing source from Iran.International microbiology : the official journal of the Spanish Society for Microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe efficient degradation of lignocellulosic biomass is essential for sustainable bioprocessing industries, including biofuel production and agro-waste valorization. This study screened bacterial isolates from black soils in Jharkhand, India, to identify strains producing cellulolytic and xylanolytic enzymes with industrial potential. Bacillus subtilis SSMK413 was selected for its coproduction of cellulase and xylanase, and the enzymes were purified and characterized for biochemical and kinetic properties. Additionally, their application in lignocellulosic biomass saccharification was evaluated to assess industrial relevance.
resultsAmong the screened bacterial isolates, Bacillus subtilis strain SSMK413, isolated from the Baulia region of Jharkhand (24.131955°N, 85.546774°E), exhibited robust coproduction of cellulase and xylanase. Primary screening on carboxymethyl cellulose (CMC) and xylan agar plates confirmed its enzymatic activities, with molecular identification via 16 S rRNA gene sequencing verifying its taxonomic classification. Optimal enzyme production was achieved after 48 h of incubation. Enzyme purification was performed using ammonium sulfate precipitation, dialysis, and Sephadex G-100 gel filtration chromatography, resulting in purification folds of 14.3 for cellulase and 11.5 for xylanase. Biochemical characterization indicated optimal activities at 40–50 °C, with pH optima of 5.0 for cellulase and 6.0 for xylanase. Enzyme activities were significantly enhanced by Mn²⁺, Mg²⁺, and Fe³⁺ ions, whereas Cs⁺ and EDTA acted as inhibitors. Kinetic studies revealed a lower Km for cellulase (0.192 mg mL− 1) compared to xylanase (2.615 mg mL− 1), indicating higher substrate affinity for cellulase. SDS-PAGE and zymogram analyses determined molecular masses of 55–65 kDa for cellulase and 240–270 kDa for xylanase, suggesting a monomeric structure for cellulase and a multimeric complex for xylanase.
conclusionsB. subtilis (SSMK413) is a promising candidate for industrial enzyme production due to its efficient coproduction of cellulase and xylanase with favorable biochemical properties. The microbial diversity from black soils in Jharkhand represents a valuable genetic resource for future biotechnological exploration. Further studies should focus on enzyme immobilization and genetic enhancement to improve catalytic efficiency and operational stability.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.